Anti-GPR151 monoclonal antibody

Pre-made anti-GPR151 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GPR151/GPR151 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0935-Ab-1/ GM-Tg-hg-IP0935-Ab-2Anti-Human GPR151 monoclonal antibodyHuman
GM-Tg-rg-IP0935-Ab-1/ GM-Tg-rg-IP0935-Ab-2Anti-Rat GPR151 monoclonal antibodyRat
GM-Tg-mg-IP0935-Ab-1/ GM-Tg-mg-IP0935-Ab-2Anti-Mouse GPR151 monoclonal antibodyMouse
GM-Tg-cynog-IP0935-Ab-1/ GM-Tg-cynog-IP0935-Ab-2Anti-Cynomolgus/ Rhesus macaque GPR151 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0935-Ab-1/ GM-Tg-felg-IP0935-Ab-2Anti-Feline GPR151 monoclonal antibodyFeline
GM-Tg-cang-IP0935-Ab-1/ GM-Tg-cang-IP0935-Ab-2Anti-Canine GPR151 monoclonal antibodyCanine
GM-Tg-bovg-IP0935-Ab-1/ GM-Tg-bovg-IP0935-Ab-2Anti-Bovine GPR151 monoclonal antibodyBovine
GM-Tg-equg-IP0935-Ab-1/ GM-Tg-equg-IP0935-Ab-2Anti-Equine GPR151 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0935-Ab-1/ GM-Tg-hg-IP0935-Ab-2; GM-Tg-rg-IP0935-Ab-1/ GM-Tg-rg-IP0935-Ab-2;
GM-Tg-mg-IP0935-Ab-1/ GM-Tg-mg-IP0935-Ab-2; GM-Tg-cynog-IP0935-Ab-1/ GM-Tg-cynog-IP0935-Ab-2;
GM-Tg-felg-IP0935-Ab-1/ GM-Tg-felg-IP0935-Ab-2; GM-Tg-cang-IP0935-Ab-1/ GM-Tg-cang-IP0935-Ab-2;
GM-Tg-bovg-IP0935-Ab-1/ GM-Tg-bovg-IP0935-Ab-2; GM-Tg-equg-IP0935-Ab-1/ GM-Tg-equg-IP0935-Ab-2
Products NameAnti-GPR151 monoclonal antibody
Formatmab
Target NameGPR151
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GPR151 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0935-Ag-1Recombinant multi-species GP151/ GPR151/ GALR4 protein


    Target information

    Target IDGM-IP0935
    Target NameGPR151
    Gene ID134391,240239,307475,708020,487201,101083825,787899,100060990
    Gene Symbol and SynonymsC130082O03Rik,GALR4,GALRL,GPCR,GPCR-2037,GPR151,nGPCR-2037,PGR7
    Uniprot AccessionQ8TDV0,Q7TSN5
    Uniprot Entry NameGP151_HUMAN,GP151_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000173250
    Target ClassificationGPCR

    The target: GPR151, gene name: GPR151, also named as GALR4, GALRL, GPCR, GPCR-2037, PGR7. This gene encodes an orphan member of the class A rhodopsin-like family of G-protein-coupled receptors (GPCRs). Within the rhodopsin-like family, this gene is a member of the SOG subfamily that includes somatostatin, opioid, galanin, and kisspeptin receptors. The orthologous mouse gene has a restricted pattern of neuronal expression which is induced following nerve injury. All GPCRs have a transmembrane domain that includes seven transmembrane alpha-helices. A general feature of GPCR signaling is the agonist-induced conformational change in the receptor, leading to activation of the heterotrimeric G protein. The activated G protein then binds to and activates numerous downstream effector proteins, which generate second messengers that mediate a broad range of cellular and physiological processes. [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.